The Selection and Use of Essential Medicines (2017) - TRS 1006

WHO Technical Report Series, No. 1006

Overview

The 21st meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines took place in Geneva, Switzerland, from 27 to 31 March 2017. The goal of the meeting was to review and update the 19th WHO Model List of Essential Medicines (EML) and the 5th WHO Model List of Essential Medicines for Children (EMLc).

The Expert Committee considered 92 applications, including proposals to add 41 new medicines and extend the indications for six existing listed medicines, five applications to delete medicines from the lists, and a comprehensive review of the antibacterials listed in sections 6.2.1 and 6.2.2 and their use in the treatment of 21 common, priority infectious syndromes, five paediatric infectious diseases and three sexually transmitted infections. In accordance with approved procedures, the Expert Committee evaluated the scientific evidence for the comparative effectiveness, safety and cost–effectiveness of the medicines.

WHO Team
Access to Medicines and Health Products (MHP), Essential Medicines (EML), Health Product Policy and Standards (HPS), Medicines Selection, IP and Affordability (MIA)
Number of pages
604
Reference numbers
ISBN: 978-92-4-121015-7
Copyright